Jie Xu , Linlin Guo , Yi Wang , Xiaoping Li , Ping Yi , Chunming Cheng
{"title":"Leveraging cancer metabolism to translate into effective therapeutics","authors":"Jie Xu , Linlin Guo , Yi Wang , Xiaoping Li , Ping Yi , Chunming Cheng","doi":"10.1016/j.semcancer.2025.12.003","DOIUrl":null,"url":null,"abstract":"<div><div>Abnormal metabolism is a typical characteristic of malignant tumors, broadly influencing the outcome of cancer therapy. Research on tumor metabolism has increased exponentially in last decades. There is an urgent need to provide a blueprint or framework to accelerate the translation of cancer metabolism research into effective therapeutics. In this review, we summarize the impact of metabolism on cancer progression and emerging metabolic therapies, and systematically outline potential clinical applications in cancer prevention, early screening, diagnosis, treatment, and new challenges. Furthermore, we aim to provide researchers and clinicians with a clearer perspective on the immediate translation of clinical applications stemming from cancer metabolism research. It will revolutionize cancer management and significantly enhance patient survival.</div></div>","PeriodicalId":21594,"journal":{"name":"Seminars in cancer biology","volume":"118 ","pages":"Pages 44-61"},"PeriodicalIF":20.3000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in cancer biology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1044579X25001737","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Abnormal metabolism is a typical characteristic of malignant tumors, broadly influencing the outcome of cancer therapy. Research on tumor metabolism has increased exponentially in last decades. There is an urgent need to provide a blueprint or framework to accelerate the translation of cancer metabolism research into effective therapeutics. In this review, we summarize the impact of metabolism on cancer progression and emerging metabolic therapies, and systematically outline potential clinical applications in cancer prevention, early screening, diagnosis, treatment, and new challenges. Furthermore, we aim to provide researchers and clinicians with a clearer perspective on the immediate translation of clinical applications stemming from cancer metabolism research. It will revolutionize cancer management and significantly enhance patient survival.
期刊介绍:
Seminars in Cancer Biology (YSCBI) is a specialized review journal that focuses on the field of molecular oncology. Its primary objective is to keep scientists up-to-date with the latest developments in this field.
The journal adopts a thematic approach, dedicating each issue to an important topic of interest to cancer biologists. These topics cover a range of research areas, including the underlying genetic and molecular causes of cellular transformation and cancer, as well as the molecular basis of potential therapies.
To ensure the highest quality and expertise, every issue is supervised by a guest editor or editors who are internationally recognized experts in the respective field. Each issue features approximately eight to twelve authoritative invited reviews that cover various aspects of the chosen subject area.
The ultimate goal of each issue of YSCBI is to offer a cohesive, easily comprehensible, and engaging overview of the selected topic. The journal strives to provide scientists with a coordinated and lively examination of the latest developments in the field of molecular oncology.